Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Research & Development
Meridian Bioscience Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Research & Development
-$24.3m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Research & Development
-$145.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-9%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Research & Development
-$180m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Align Technology Inc
NASDAQ:ALGN
|
Research & Development
-$351.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-22%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Research & Development
-$95.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-16%
|
See Also
What is Meridian Bioscience Inc's Research & Development?
Research & Development
-24.3m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Research & Development amounts to -24.3m USD.
What is Meridian Bioscience Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-9%
Over the last year, the Research & Development growth was -2%. The average annual Research & Development growth rates for Meridian Bioscience Inc have been -11% over the past three years , -9% over the past five years .